# Vertos Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vertos-medical

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.vertosmed.com
- Total disclosed funding: $108M
- Latest round: Series C (May 22, 2023)
- Investors on record: 9

## About

Founded in 2005 and based in California, US, Vertos Medical Inc., formerly known as X-Sten Corp., operates as a medical device company. In August 2024, Stryker Corporation agreed to acquire Vertos Medical Inc. from Welsh, Carson, Anderson & Stowe, Norwest Venture Partners, Foundation Medical Partners, and ONSET Ventures. As of 2024, the company is led by its president and CEO, Eric Wichems.

Vertos Medical develops and offers minimally invasive solutions for Lumbar Spinal Stenosis (LSS). The company’s product line includes mild®, a minimally invasive outpatient procedure designed to address LSS, a condition where the lower spinal canal narrows and compresses nerves. The firm provides education and training for healthcare professionals about the mild® procedure and its benefits. Additionally, the company also provides clinical support to physicians and other healthcare providers who use the mild® procedure.

Following the August 2024 acquisition, the company plans to support the expansion of its interventional pain management solutions.

## Funding rounds

- Series C, May 22, 2023, $45M — Pitango, Norwest Venture Partners, Partner Ventures
- Series E, Jun 17, 2013, $23M — CHL Medical Partners, Pitango, Foundation Medical Partners, ONSET Ventures, Aweida Venture Partners, Mercury
- Series D, May 13, 2011, $8M — CHL Medical Partners, Welsh, Carson, Anderson & Stowe, Foundation Medical Partners, ONSET Ventures, Mercury
- Series D, Oct 15, 2009, $16M — CHL Medical Partners, Foundation Medical Partners, ONSET Ventures, Aweida Venture Partners, Mercury
- Series C, Jul 17, 2008, $12M — CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners, Mercury
- Series B, Mar 1, 2007, $4.2M — Mercury
- Series A, Apr 25, 2006, $0.7M — Mercury

## Investors

- Mercury (https://capitalatlas.ai/funds/mercury) — Series A, Series B, Series C, Series D, Series E
- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series C, Series D, Series E
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series C, Series D, Series E
- Aweida Venture Partners (https://capitalatlas.ai/funds/aweida-venture-partners) — Series C, Series D, Series E
- ONSET Ventures (https://capitalatlas.ai/funds/onset-ventures) — Series D, Series E
- Welsh, Carson, Anderson & Stowe (https://capitalatlas.ai/funds/welsh-carson-anderson-stowe) — Series D
- Pitango (https://capitalatlas.ai/funds/pitango) — Series E, Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series C
- Partner Ventures (https://capitalatlas.ai/funds/partner-ventures) — Series C